{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:35:17Z","timestamp":1790487317211,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.vaccine.2021.08.011","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T22:39:18Z","timestamp":1628807958000},"page":"5358-5367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3046-7053","authenticated-orcid":false,"given":"Helen","family":"Webster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5901-6806","authenticated-orcid":false,"given":"Cliburn","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0833-2635","authenticated-orcid":false,"given":"Maria","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Roark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinu","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Carfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallie R.","family":"Permar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2021.08.011_b0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.011_b0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcv.2007.09.004","article-title":"Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment","volume":"41","author":"Grosse","year":"2008","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.011_b0015","first-page":"39","article-title":"Awareness of Congenital Cytomegalovirus in the United States","volume":"1","author":"Doutre","year":"2016","journal-title":"Journal of Early Hearing Detection and Intervention"},{"key":"10.1016\/j.vaccine.2021.08.011_b0020","unstructured":"Medicine, I.o., Vaccines for the 21st Century: A Tool for Decisionmaking, ed. K.R. Stratton, J.S. Durch, and R.S. Lawrence. 2000, Washington, DC: The National Academies Press. 472."},{"issue":"24","key":"10.1016\/j.vaccine.2021.08.011_b0025","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions","volume":"115","author":"Nelson","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2021.08.011_b0030","doi-asserted-by":"crossref","unstructured":"Leruez-Ville, M., et al., Risk Factors for Congenital Cytomegalovirus Infection Following Primary and Nonprimary Maternal Infection: A Prospective Neonatal Screening Study Using Polymerase Chain Reaction in Saliva. Clin Infect Dis, 2017. 65(3): p. 398-404.","DOI":"10.1093\/cid\/cix337"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.011_b0035","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3390\/v6041483","article-title":"Using the nonhuman primate model of HCMV to guide vaccine development","volume":"6","author":"Deere","year":"2014","journal-title":"Viruses"},{"issue":"30","key":"10.1016\/j.vaccine.2021.08.011_b0040","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.vaccine.2014.05.004","article-title":"Human cytomegalovirus gH\/gL\/UL128\/UL130\/UL131A complex elicits potently neutralizing antibodies in mice","volume":"32","author":"Wen","year":"2014","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2021.08.011_b0045","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","article-title":"Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2021.08.011_b0050","doi-asserted-by":"crossref","unstructured":"Burke, H.G. and E.E. Heldwein, Crystal Structure of the Human Cytomegalovirus Glycoprotein B. PLoS Pathog, 2015. 11(10): p. e1005227.","DOI":"10.1371\/journal.ppat.1005227"},{"key":"10.1016\/j.vaccine.2021.08.011_b0055","doi-asserted-by":"crossref","unstructured":"Wussow, F., et al., Human cytomegalovirus vaccine based on the envelope gH\/gL pentamer complex. PLoS Pathog, 2014. 10(11): p. e1004524.","DOI":"10.1371\/journal.ppat.1004524"},{"issue":"568","key":"10.1016\/j.vaccine.2021.08.011_b0060","doi-asserted-by":"crossref","first-page":"eabb3611","DOI":"10.1126\/scitranslmed.abb3611","article-title":"Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB\/MF59 vaccine in humans","volume":"12","author":"Jenks","year":"2020","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.011_b0065","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.08.011_b0070","unstructured":"Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults. [Website] 2020-2021 7\/13\/2021 7\/30\/3031]; Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04232280?id=NCT04232280&draw=2&rank=1&load=cart."},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.011_b0075","first-page":"1397","article-title":"Characterization of a messenger RNA polynucleotide vaccine vector","volume":"55","author":"Conry","year":"1995","journal-title":"Cancer Res"},{"issue":"7644","key":"10.1016\/j.vaccine.2021.08.011_b0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2021.08.011_b0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-017-0032-6","article-title":"Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines","volume":"2","author":"Lutz","year":"2017","journal-title":"npj Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.011_b0090","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol Ther"},{"issue":"10","key":"10.1016\/j.vaccine.2021.08.011_b0095","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2013developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2021.08.011_b0100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J Control Release"},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.011_b0105","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.vaccine.2018.01.029","article-title":"Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity","volume":"36","author":"John","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.011_b0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00430-007-0073-y","article-title":"Rhesus CMV: an emerging animal model for human CMV","volume":"197","author":"Powers","year":"2008","journal-title":"Med Microbiol Immunol"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2021.08.011_b0115","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1099\/0022-1317-78-8-1999","article-title":"Identification of the gene coding for rhesus cytomegalovirus glycoprotein B and immunological analysis of the protein","volume":"78","author":"Kropff","year":"1997","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.011_b0120","first-page":"43","article-title":"Development of breeding populations of rhesus macaques (Macaca mulatta) that are specific pathogen-free for rhesus cytomegalovirus","volume":"58","author":"Barry","year":"2008","journal-title":"Comp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.011_b0125","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/v13061106","article-title":"Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity","volume":"13","author":"Wang","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2021.08.011_b0130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1743-422X-6-210","article-title":"High genotypic diversity and a novel variant of human cytomegalovirus revealed by combined UL33\/UL55 genotyping with broad-range PCR","volume":"6","author":"Deckers","year":"2009","journal-title":"Virol J"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.011_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015949","article-title":"Detection of a single identical cytomegalovirus (CMV) strain in recently seroconverted young women","volume":"6","author":"Murthy","year":"2011","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.011_b0140","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1128\/JCM.01341-08","article-title":"Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay","volume":"46","author":"Pang","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.011_b0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.virol.2010.12.049","article-title":"Isolation and characterization of cynomolgus macaque (Macaca fascicularis) cytomegalovirus (CyCMV)","volume":"412","author":"Ambagala","year":"2011","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.011_b0150","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1128\/JVI.77.12.6620-6636.2003","article-title":"Complete sequence and genomic analysis of rhesus cytomegalovirus","volume":"77","author":"Hansen","year":"2003","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2021.08.011_b0155","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1128\/IAI.71.10.5831-5844.2003","article-title":"Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection","volume":"71","author":"Capuano","year":"2003","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2021.08.011_b0160","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1128\/JVI.02525-10","article-title":"A novel respiratory model of infection with monkeypox virus in cynomolgus macaques","volume":"85","author":"Goff","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.08.011_b0165","doi-asserted-by":"crossref","unstructured":"Lawler, J.V., et al., Cynomolgus macaque as an animal model for severe acute respiratory syndrome. PLoS Med, 2006. 3(5): p. e149.","DOI":"10.1371\/journal.pmed.0030149"},{"key":"10.1016\/j.vaccine.2021.08.011_b0170","doi-asserted-by":"crossref","unstructured":"Burwitz, B.J., et al., Cross-Species Rhesus Cytomegalovirus Infection of Cynomolgus Macaques. PLoS Pathog, 2016. 12(11): p. e1006014.","DOI":"10.1371\/journal.ppat.1006014"},{"key":"10.1016\/j.vaccine.2021.08.011_b0175","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12864-016-2588-3","article-title":"A novel strain of cynomolgus macaque cytomegalovirus: implications for host-virus co-evolution","volume":"17","author":"Russell","year":"2016","journal-title":"BMC Genomics"},{"issue":"24","key":"10.1016\/j.vaccine.2021.08.011_b0180","doi-asserted-by":"crossref","first-page":"12995","DOI":"10.1128\/JVI.05840-11","article-title":"Genomic sequencing and characterization of cynomolgus macaque cytomegalovirus","volume":"85","author":"Marsh","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.08.011_b0185","doi-asserted-by":"crossref","unstructured":"Potzsch, S., et al., B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies. PLoS Pathog, 2011. 7(8): p. e1002172.","DOI":"10.1371\/journal.ppat.1002172"},{"issue":"24","key":"10.1016\/j.vaccine.2021.08.011_b0190","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1073\/pnas.1800224115","article-title":"Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies","volume":"115","author":"Baraniak","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.011_b0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/viro.1996.0040","article-title":"Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures","volume":"216","author":"Schoppel","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2021.08.011_b0200","doi-asserted-by":"crossref","unstructured":"Barouch, D.H., et al., Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys. Cell, 2013. 155(3): p. 531-9.","DOI":"10.1016\/j.cell.2013.09.061"},{"issue":"9","key":"10.1016\/j.vaccine.2021.08.011_b0205","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1099\/0022-1317-73-9-2375","article-title":"Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies","volume":"73","author":"Meyer","year":"1992","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2101029X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2101029X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:59:40Z","timestamp":1759402780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2101029X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":41,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0264410X2101029X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}